Home
About BCG
Contact Us
Locations
Services
Areas of Expertise
Regulatory Library
Newsletter Archive
Useful Web Links
Presentations
 

 

 



 

Holli S. Vaughan, MS. RAC


EDUCATION:

M.S.   Johns Hopkins University; Interdisciplinary Scientific Studies, Biology; (1995)
B.S.   Mary Washington College; Biology; (1988)
Continuing Education:  
  • Clinical Statistics for Non-Statisticians Training Course (March 1999)
  • A Joint FDA and DIA Project Management Training Workshop (October 1997)
  • Regulatory Policy Issues in the Development and Manufacture of Biopharmaceuticals and Other Biotechnology Derived Products (November 1995)
  • Conducting Successful Negotiations in Regulatory Affairs Workshop (May 1995)
  • Biologics Approval and Compliance Workshop (October 1994)

EXPERIENCE:

CURRENT POSITION:
March 2000 to
present:
 

Associate - Biologics Consulting Group, Inc
Alexandria, VA.


Oct. 1993 to Mar. 2000 Manager, Regulatory Affairs for Pharma Pacific Pty. Ltd., Arlington, VA..
  • Responsible for all regulatory activities in the Americas for Australian-based bio-pharmaceutical company.
    • Planned and prepared regulatory submissions and documents
    • Drafted and edited protocols and final reports
    • Researched and wrote scientific literature reviews
    • Created standard operating procedures for key regulatory and clinical functions
    • Ensured data quality and integrity
    • Participated in a due diligence preclinical review.
  • Managed all aspects of research development projects.
    • Directly involved with product development strategies and planning.
    • Coordinated the design, initiation and completion of preclinical and clinical studies.
    • Worked with a wide range of professionals including manufacturing, marketing and business development personnel, independent consultants, clinical research organizations, principal investigators, scientific review committees and peer review boards.
    • Budgeted and executed service agreements with selected principal investigators, academic institutions and contract research laboratories.
  • Researched Latin American regulatory requirements and processes, and potential commercial partners for business development evaluation.
  • Presented research and program updates to upper management, consultants, investigators and international commercial partners on a frequent basis.

Dec. 1992 to Sept. 1993   Regulatory Affairs Associate for the FIDIA Pharmaceutical Corporation, Washington, DC.
  • Wrote and prepared protocol and information amendments, safety reports and annual progress reports for Investigational New Drug (IND) applications, Investigational Device Exemptions and Pre-market Approval applications.  Assisted physicians with preparing Sponsor-Investigator INDs.
  • Worked with microbiologists and manufacturing personnel in formulating responses to regulator inquiries.
  • Supervised and coordinated the labeling and packaging of investigational drug supplies.

May 1991 to Dec. 1992 Regulatory Affairs Section Leader for Social & Scientific Systems, Inc., Rockville, MD.

May 1988 to April 1991   International Regulatory Affairs Assistant for Anaquest, Inc., Murray Hill, NJ.
  • Prepared and submitted regulatory submissions into 14 foreign countries for marketed and/or investigational pharmaceutical products.  Facilitated the regulatory process by liaising with foreign governmental authorities, consultants and all company departments.

CERTIFICATIONS:

Nov. 2001   RAC Certified; Regulatory Affairs Professional Society (RAPS)

PROFESSIONAL AFFILIATIONS:

  Regulatory Affairs Professional Society (RAPS)
  Drug Information Association (DIA)
 
Paged Updated: July 25, 2007